Home/Recalls/FDA-D-0300-2026
FDA DrugsClass III

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured ...

Published: February 4, 2026Recall ID: D-0300-2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed Impurities/Degradation Specifications

Product Description & Identification

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Additional Source Details

FieldValue
CityPiscataway
StateNJ
Openfda › UniiV92SO9WP2I
Openfda › RouteORAL
Openfda › Rxcui999961
Openfda › Spl id98820c01-1853-45d8-9da5-875fcdf5f9ab
Openfda › Brand nameGLYCOPYRROLATE
Openfda › Spl set id98820c01-1853-45d8-9da5-875fcdf5f9ab
Openfda › Package ndc72205-070-72
Openfda › Product ndc72205-070
Openfda › Generic nameGLYCOPYRROLATE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameGLYCOPYRROLATE
Openfda › Manufacturer nameNovadoz Pharmaceuticals LLC
Openfda › Application numberANDA216084
Openfda › Is original packagertrue
Event id98156
Address 120 Duke Rd Ste A
Address 2N/A
Code infoLot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Postal code08854-3714
Report date20260204
Product typeDrugs
Product quantityN/A
Reason for recallFailed Impurities/Degradation Specifications
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251215
Initial firm notificationLetter
Center classification date20260128

Overview

  • Recalling FirmNOVADOZ PHARMACEUTICALS LLC
  • StatusOngoing
  • Risk LevelClass III
  • DistributionUS Nationwide.
Official Agency Alert